The global roadside drug testing devices market size was USD 445.1 Million in 2022 and is expected to register a revenue CAGR of 5.5% during the forecast period.
Report Scope of the Roadside Drug Testing Devices Market:
|The market size value in 2022||USD 445.1 Million|
|CAGR (2022 – 2032)||5.5%|
|The Revenue forecast in 2032||USD 761.2 Million|
|Base year for estimation||2023|
|Report coverage||Revenue forecast, company ranking, competitive landscape, growth factors, and trends|
Fatalities and injuries as a result of drinking and driving are increasing. As per the statistics provided by the U.S. Department of Transportation, around one person in every 45 minutes, lose their life in drunk driving accidents in the U.S. 11,654 persons died in traffic accidents as a result of drunk driving in 2020, which is a 14% rise from 2019. According to a 2020 research by the Parliamentary Advisory Council for Transport Safety (PACTS), approximately 210 road users died in collisions in the U.K. in which the driver of the vehicle had consumed too much alcohol. An estimated 7,800 individuals were injured or died in accidents in the same year that involved at least one motorist who had consumed more alcohol than was permitted.
Request a Sample@ https://www.qyresearchmedical.com/sample/119561
Government authorities in various countries are also introducing favorable legislation to control alcohol and drug consumption, which is eventually leading to market expansion. For instance, according to the Road Traffic Act of Japan, driving while intoxicated carries serious consequences. A driver is deemed to be Driving Under the Influence (DUI) at an alcohol concentration of 0.15 mg per 1L of breath. DUI is penalized by up to three years in jail with hard labor and a fine of up to an amount of approximately USD 4,000. Driving While Intoxicated (DWI) is punishable by up to five years in jail with hard labor and an amount of approximately USD 7,500 fine. Consequences are worse if a DUI or DWI occurrence causes an accident. Drivers who cause someone else’s death or serious injury while impaired by drugs or alcohol are subject to up to 20 years in jail with hard labor (in the case of a fatality) or 15 years in prison without parole (in the case of an injury).
Restraint: Invasion of privacy along with inaccurate results of drug testing devices
Following the legalization of marijuana, several states in the U.S. are exploring for novel approaches to deter impaired driving. Several plans would result in questionable and potentially unconstitutional police activities. Roadside saliva testing without a warrant is one such notion. These tests raise severe issues with equal protection and due processes. Roadside saliva testing without a warrant is one such notion. These tests raise severe issues with equal protection and due process. According to the Fourth Amendment, roadside stops are seizures. Whether or not a particular seizure is legal depends on a variety of variables. These warrantless tests will undoubtedly result in prolonged seizures and interrogation techniques with disorders who lawfully take the tested-for, physician medicines than those who do not as they will be positive for commonly used drugs, such as anti-depressants and pain relievers.
Key companies profiled
Some of the major companies included in the global market report are Alcohol Countermeasure Systems Corp., American Screening Corporation, Inc., Abbott Laboratories, Drägerwerk AG &Co. KGaA, Intoximeters, Lifeloc Technologies, Inc., AK GlobalTech Corp., Oranoxis, Mavand Solutions GmbH, and Thermo Fisher Scientific Inc.
Roadside Drug Testing Devices Market Segmentations:
|By Device Type Outlook||By Application Outlook||By Substance Outlook|
Alcosensor III or IV
Semiconductor Oxide Sensor
Infrared (IR) Spectroscopy
|By Sample Type Outlook||By End-use Outlook|
Drug Enforcement Agency
Bars and Restaurants
Buy quantitative research Report at discounted price – USD 1599 https://www.qyresearchmedical.com/report/checkout/119561/
You can place an order or ask any questions, please feel free to contact [email protected] | +1 9197 992 333
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us:
URL – http://www.qyresearchmedical.com/